In CRC, previous studies have reported 35-37 that elevated E2F1 expression exhibits an inverse association with cell proliferation and a positive correlation with increased apoptotic levels, suggesting a tumor-suppressive role in CRC progression. The gene discussed is E2F1; the disease is colorectal carcinoma.